Dr. Brendan Christopher Visser, MD

Dr. Visser practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Visser's NPI, 1134210628, was assigned on September 27, 2006. Dr. Visser graduated from UCSF School of Medicine in 1999. Dr. Visser holds California license A74028.

Dr. Visser's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Visser's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Visser is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Visser to 1 more hospital, named with a free account. Dr. Visser's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Visser practices, 3 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Visser's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Visser is board certified in surgery by the American Board of Surgery. Dr. Visser is licensed in California.

Dmand AI lists acute gallbladder or bile duct inflammation, colonoscopy, colon removal, esophagus, stomach, or upper small intestine surgery, gallbladder removal and upper GI endoscopy among the conditions Dr. Visser treats.

CMS data shows 402 Medicare services from Dr. Visser across 7 procedure codes in 2024, for 299 Medicare patients. Medicare paid $106,963 for them.

CMS counts 299 Medicare patients who saw Dr. Visser in 2024. The largest group is 65 to 74, with 135 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Visser's median patient age at 65, with 50% women.

In 2024, Dr. Visser wrote 118 Medicare Part D claims for 46 patients. 68% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $1,398 in total drug cost. In 2023, CMS named 19 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Visser for performance year 2024, reported as part of a group. Dr. Visser accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Visser as offering telehealth.

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 176 papers to Dr. Visser, published from 2010 to 2025. 2022 was the busiest year, with 10. The most frequent topics are Pancreatic Neoplasms, Pancreatectomy and Liver Neoplasms. Dr. Visser has published most often in HPB (Oxford). Dr. Visser's most frequent co-authors are Monica Makiko Dua, MD, Jeffrey A. Norton, MD and George A. Poultsides, MD.

Dmand AI links Dr. Visser to 1 clinical trial. Conditions studied include Pancreatic Neoplasms and Pancreatic Diseases.

CMS Open Payments shows 30 general payments to Dr. Visser from 11 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 28% of the total. Intuitive Surgical, Inc. paid the most, $2,655.

Dmand AI lists 2 awards for Dr. Visser, most recently CMS Stage 1 EHR in 2013.

Dr. Visser graduated from UCSF School of Medicine in 1999. Dr. Visser is a member of ACS.

Dr. Visser is in network with 15 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.